Generating AI analysis...
AI Earnings Analysis
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Revenue | $10.46B | $10.41B | +0.44% |
Operating Income | $2.7B | $3B | -10.08% |
Net Income | $3.66B | $3.49B | +4.73% |
EPS (Basic) | $34.83 | $32.36 | +7.63% |
EPS (Diluted) | $33.61 | $30.23 | +11.18% |
R&D Expense | $4.22B | $3.72B | +13.55% |
SG&A Expense | $1.93B | $2.16B | -10.97% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Total Assets | $40.17B | $37.44B | +7.28% |
Current Assets | $17.98B | $19.33B | -7.00% |
Total Liabilities | $9.21B | $8.12B | +13.50% |
Current Liabilities | $4.43B | $3.66B | +20.87% |
Stockholders' Equity | $30.96B | $29.33B | +5.56% |
Cash & Equivalents | $2.51B | $2.01B | +24.58% |
Long-Term Debt | $1.99B | $1.98B | +0.08% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Cash Flow | $3.81B | $3.16B | +20.60% |
Investing Cash Flow | $-849.4M | $-2.82B | +69.87% |
Financing Cash Flow | $-2.94B | $-1.06B | -175.62% |
Dividends Paid | $277.6M | $0 | — |
Share Buybacks | $2.77B | $1.63B | +69.72% |
D&A | $398.7M | $356.5M | +11.84% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Margin | 25.8% | 28.8% | -3.02% |
Net Margin | 35.0% | — | — |
ROE | 11.8% | — | — |
ROA | 9.1% | — | — |
Current Ratio | $4.063 | — | — |
Debt to Equity | $0.298 | — | — |
Other companies in Biotechnology